ALX Oncology Holdings Inc. Common Stock (ALXO) is a publicly traded Healthcare sector company. As of July 28, 2026, ALXO trades at $2.02 with a market cap of $273.16M and a P/E ratio of -1.09. ALXO moved -0.74% today. Year to date, ALXO is +78.76%; over the trailing twelve months it is +283.88%. Its 52-week range spans $0.40 to $2.66. Analyst consensus is strong buy with an average price target of $4.67. Rallies surfaces ALXO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALX Oncology Holdings Inc. Common Stock (ALXO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALXO moved -0.74% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.02 |
| Market Cap | $273.16M |
| P/E Ratio | -1.09 |
| EPS | $-1.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.66 |
| 52-Week Low | $0.40 |
| Volume | 331.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-101.69M |
| Gross Margin | 0.00% |
4 analysts cover ALXO: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.67.